Trial NCT01087203

View at ClinicalTrials.gov 
Org. Study IDs: A4091031
Secondary IDs: DPN PHASE 2B

Last trial update was posted on 2021-02-24

MeSH Interventions

Tanezumab

MeSH Conditions

Diabetic Neuropathies Peripheral Nervous System Diseases

Other Conditions

Diabetic Peripheral Neuropathy

Stopping Reasons

See termination reason in detailed description.

Limitations And Caveats

This study was terminated following a United States (US) Food and Drug Administration (FDA) partial clinical hold.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID